U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the ...

The White House blamed exposure to environmental toxins, poor nutrition and increased screen time for a decline in Americans’ ...

"The trust issues are quite far-reaching" and impact public perception towards health-based changes across the U.S., a health ...

Calley Means, a health care entrepreneur, coordinated a presidential commission report on chronic diseases in children.

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

Despite low obesity rates, Korea sees high demand for Wegovy, prompting misuse and regulatory concerns amid societal ...

Supermarket pharmacies are doubling down on healthcare accessibility and food-as-medicine initiatives as consumer confidence ...